Endoscopic Metabolic and Bariatric Therapies
Public ClinicalTrials.gov record NCT05725967. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Study identification
- NCT ID
- NCT05725967
- Recruitment status
- Enrolling by invitation
- Study type
- Observational
- Phase
- Not listed
- Lead sponsor
- Christopher C. Thompson, MD, MSc
- Other
- Enrollment
- 5,000 participants
Conditions and interventions
Conditions
- Abdominal Obesity
- Abdominal Pain
- Bariatric Surgery Candidate
- Complication of Surgical Procedure
- Complication of Treatment
- Complication,Postoperative
- Delayed Gastric Emptying Following Procedure
- Fistula, Gastric
- Leak, Anastomotic
- Obesity
- Obesity Associated Disorder
- Obesity, Morbid
- Roux-en-y Anastomosis Site
- Ulcer, Gastric
- Weight Gain
- Weight Loss
Interventions
- Argon Plasma Coagulation, Gastroplasty with Endoscopic Myotomy, Bariatric Endoscopic Antral Myotomy, Pylorus Sparing Antral Myotomy Device
- Aspiration Therapy Device
- Bariatric Surgery Procedures Procedure
- Endoscopic Revision of Bariatric Surgical Procedures Procedure
- Endoscopic Sleeve Gastroplasty, Trans-oral Outlet Reduction Device
- Intragastric Balloon Device
- Primary Obesity Endoscopic Procedures Procedure
- Primary obesity surgery endoluminal, Restorative obesity surgery endoluminal Device
Device · Procedure
Eligibility (public fields only)
- Age range
- 18 Years to 80 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jul 7, 2022
- Primary completion
- May 27, 2028
- Completion
- May 27, 2029
- Last update posted
- Dec 1, 2025
2022 – 2029
United States locations
- U.S. sites
- 1
- U.S. states
- 1
- U.S. cities
- 1
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Brigham and Women's Hospital | Boston | Massachusetts | 02115 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT05725967, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Dec 1, 2025 · Synced May 20, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT05725967 live on ClinicalTrials.gov.